This trial is significant because pancreatic cancer is one of the most difficult solid tumour cancers to treat and the progress in treatments has been slow, says Dr Shailesh Shrikhande, who heads India's highest volume centre for pancreatic cancer surgery at Mumbai’s Tata Memorial Hospital